157 related articles for article (PubMed ID: 1678853)
1. Comparisons of the combined contributions of agonist binding frequency and intrinsic efficiency to receptor-mediated activation of adenylate cyclase.
Stickle D; Barber R
Mol Pharmacol; 1991 Aug; 40(2):276-88. PubMed ID: 1678853
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the role of epinephrine binding frequency in activation of adenylate cyclase.
Stickle D; Barber R
Mol Pharmacol; 1989 Sep; 36(3):437-45. PubMed ID: 2550777
[TBL] [Abstract][Full Text] [Related]
3. Analysis of receptor-mediated activation of GTP-binding protein/adenylate cyclase using the encounter coupling model.
Stickle D; Barber R
Mol Pharmacol; 1993 Mar; 43(3):397-411. PubMed ID: 8095693
[TBL] [Abstract][Full Text] [Related]
4. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors.
Contreras ML; Wolfe BB; Molinoff PB
J Pharmacol Exp Ther; 1986 Apr; 237(1):154-64. PubMed ID: 2870174
[TBL] [Abstract][Full Text] [Related]
5. Beta adrenergic receptor subtypes in the atria: evidence for close coupling of beta-1 and beta-2 adrenergic receptors to adenylate cyclase.
Liang BT; Molinoff PB
J Pharmacol Exp Ther; 1986 Sep; 238(3):886-92. PubMed ID: 2875173
[TBL] [Abstract][Full Text] [Related]
6. The encounter coupling model for beta-adrenergic receptor/GTP-binding protein interaction in the S49 cell. Calculation of the encounter frequency.
Stickle D; Barber R
Biochem Pharmacol; 1992 May; 43(9):2015-28. PubMed ID: 1350723
[TBL] [Abstract][Full Text] [Related]
7. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
Hoyer D; Reynolds EE; Molinoff PB
Mol Pharmacol; 1984 Mar; 25(2):209-18. PubMed ID: 6142414
[TBL] [Abstract][Full Text] [Related]
8. Effects of ethanol in vitro on the beta adrenergic receptor-coupled adenylate cyclase system.
Bode DC; Molinoff PB
J Pharmacol Exp Ther; 1988 Sep; 246(3):1040-7. PubMed ID: 2843625
[TBL] [Abstract][Full Text] [Related]
9. Desensitization and resensitization of beta-adrenergic receptors in a smooth muscle cell line.
Scarpace PJ; Baresi LA; Sanford DA; Abrass IB
Mol Pharmacol; 1985 Dec; 28(6):495-501. PubMed ID: 2867463
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of beta-2 adrenergic receptors of high coupling efficiency in human neutrophil sonicates.
Galant SP; Allred SJ
J Lab Clin Med; 1980 Jul; 96(1):15-23. PubMed ID: 6248606
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. II. Agonist binding to soluble beta adrenergic receptors.
Contreras ML; Wolfe BB; Molinoff PB
J Pharmacol Exp Ther; 1986 Apr; 237(1):165-72. PubMed ID: 2870175
[TBL] [Abstract][Full Text] [Related]
12. Binding and functional characteristics of beta adrenergic receptors in the intact neutrophil.
Galant SP; Allred S
J Lab Clin Med; 1981 Aug; 98(2):227-37. PubMed ID: 6265572
[TBL] [Abstract][Full Text] [Related]
13. Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist.
Scarpace PJ; Abrass IB
J Pharmacol Exp Ther; 1982 Nov; 223(2):327-31. PubMed ID: 6127402
[TBL] [Abstract][Full Text] [Related]
14. The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.
Waelbroeck M; Taton G; Delhaye M; Chatelain P; Camus JC; Pochet R; Leclerc JL; De Smet JM; Robberecht P; Christophe J
Mol Pharmacol; 1983 Sep; 24(2):174-82. PubMed ID: 6136901
[TBL] [Abstract][Full Text] [Related]
15. Beta-adrenergic receptors, cyclic AMP, and ion transport in the avian erythrocyte.
Aurbach GD; Spiegel AM; Gardner JD
Adv Cyclic Nucleotide Res; 1975; 5():117-32. PubMed ID: 165661
[TBL] [Abstract][Full Text] [Related]
16. Altered adrenergic response and specificity of the receptors in rat ascites hepatoma AH130.
Sanae F; Miyamoto K; Koshiura R
Cancer Res; 1989 Nov; 49(22):6242-6. PubMed ID: 2553251
[TBL] [Abstract][Full Text] [Related]
17. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
Costa T; Klinz FJ; Vachon L; Herz A
Mol Pharmacol; 1988 Dec; 34(6):744-54. PubMed ID: 2849042
[TBL] [Abstract][Full Text] [Related]
18. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
Zaremba TG; Fishman PH
Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420
[TBL] [Abstract][Full Text] [Related]
19. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists.
Neve KA; Barrett DA; Molinoff PB
J Pharmacol Exp Ther; 1985 Dec; 235(3):657-64. PubMed ID: 2867205
[TBL] [Abstract][Full Text] [Related]
20. Homologous desensitization of the beta-adrenergic receptor. Functional integrity of the desensitized receptor from mammalian lung.
Strasser RH; Cerione RA; Codina J; Caron MG; Lefkowitz RJ
Mol Pharmacol; 1985 Sep; 28(3):237-45. PubMed ID: 2993846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
